Share on Pinterest
MarkHatfield/Getty Images

We admit products we recall are useful for our readers. If you buy through links connected this page, we may earn a small commission. Here's our process.

For anyone taking long-acting and short-performing (pre-meal) insulin, an insulin ticker offers freedom from entirely of the hassle of injections.

If you decide to eat a little more, or do some unexpected exercise, you throne just campaign a button to administer close to insulin. And the pump's continuous background drip of insulin mimics the action of a healthy pancreas, thus your rake saccharify levels can remain more steadier.

Traditionally, insulin pumps were stand-alone devices. Just in recent years, they're increasingly connected to a perpetual glucose monitor (CGM) to make over a more automated glucose monitoring and insulin dosing jazz group marketed as a "closed loop system."

Whether the pump is connected to a CGM or not, the person exhausting it still plays an important function in determining how much insulin they need and when they need IT, especially around meals.

Simply No worries — modern pumps are very intuitive and easy to use. And there's No age terminal point on using a pump; they are used away children, clear heavenward to older adults.

Read on to learn about current insulin pumps in the United States approved by the FDA (FDA), any older models still in use, and a glance at next-gen insulin pump engineering science that's happening the horizon.

Here is a summing up of the existing insulin pumps on the market in the United States (listed in script order) and what they offer to people with diabetes:

Tandem t:thin X2

The X2 is the latest iteration of the signature touch screen insulin pump from California company Tandem Diabetes Care, first introduced back in 2012. The X2 has built-in Bluetooth connectivity, and received Food and Drug Administration clearance in 2016. It was launched to market the following year.

Tandem's t:reduce X2 is a traditional tubed insulin ticker, meaning insulin is delivered via a abundant plastic cannula connected to the body via an infusion set. What makes it stand out from competitors are the color touchscreen display and innovative insulin cartridge design. Tandem's cartridge uses a bag of insulin rather than a clear, insensitive-cause reservoir inside like to the highest degree of the another tubed pumps.

What's also unique about t:slim X2 is the capability to update the unit remotely from home, a first in the diabetes pump world. This means users crapper update the pump's features just by plugging the device into a computer and connecting to Bicycle-built-for-two's updater site, sort o than needing to buy a whole new expensive man of hardware.

The latest iterations of this pump bring to a greater extent closed loop capabilities: either an auto-insulin shutoff feature known as Basal-Intelligence quotient, launched in 2018, or their more civilized Control-IQ algorithm, launched in early 2020, that car-adjusts insulin legal transfer to offset high blood sugars.

Currently, this pump only whole kit and caboodle with the Dexcom CGM, but Tandem has agreements for future integration with otherwise CGMs, including the Abbott FreeStyle Libre flash glucose monitor.

Medtronic Minimed 670G and 770G Hybrid Closed Loop

Medtronic has been a long-term-clock time loss leader in tubed insulin ticker engineering science. They are besides the only company that manufactures both a pump and a CGM.

In fact, Medtronic is the oldest pump companionship on the market, origin with their acquisition of Minimed back in 2001. Their traditonal horizontally-oriented pumps looked similar to pagers, just those aged iterations have got now officially been discontinued and replaced with the "6-series" that take over a much current look and semi-erect orientation.

Their Minimed 670G was Food and Drug Administration-approved in 2016 as the first-ever "hybrid out of use loop system" that can mechanically monitor glucose and adjust base insulin doses, approved for use past mass 14 and older with typecast 1 diabetes (T1D). Thae 670G monitors glucose using Medtronic's Shielder 3 CGM and automatically adjusts basic insulin to keep users as close as accomplishable to the fixed target blood glucose level of 120 mg/dL.

It has the power to predictively alert users to impendent low blood sugars, and can adjust insulin consequently or tight off background insulin if the user reaches a low threshold. It was dubbed a "hybrid" closed loop upon launch because it does not take terminated glucose verify completely as is expected from a full staged pancreas.

You can study nearly users' experiences with the 670G in our review here.

In 2020, Medtronic launched the 770G. With the duplicate form factor as the 670G, this newer model adds Bluetooth connectivity soh that it hindquarters work with smartphone apps. Importantly, this system is FDA approved for adults and kids atomic number 3 young as 2 years old right from the start — alternatively of starting with adults and doing pediatric studies later, which is traditionally the case.

This 770G variant is also the platform that will equal used for the company's future tech, which is a more advanced and personalized closed-loop system system. This is the ticker that Medtronic is now selling A IT's most latest model in the United States, and updating those who have been using the earlier models.

Omnipod tubeless patch pump

The exclusively replete-featured tubeless insulin heart on the market is made by the Boston-area company Insulet Corporation.

Maiden launched in 2005, this system has asleep through and through a couple of iterations before the Omnipod DASH system was free in 2019. Insulin is delivered via a small pod with an adhesive back that's cragfast onto your skin, that is restricted via wireless connection to a hand-held PDM (Person-to-person Diabetes Manager). The DASH model has built-in Bluetooth and touch screen PDM with color display.

The newest Omnipod also no longer houses a inbuilt fingerstick glucose meter as earlier models did.

Omnipod doesn't currently allow for remote ascendence of insulin delivery via a mobile smartphone app. But that is upcoming soom in the newest Omnipod 5 model (formerly titled Omnipod Horizon), which will cost Insulet's showtime closed loop technical school that works with the Dexcom G6 CGM. That is potential in late 2021 operating theatre early 2022.

While insulin pumps accept largely been aimed at the T1D population of people on intensive insulin therapy, data shows these devices can have a huge benefit for those living with typecast 2 diabetes (T2D) who use insulin as well.

On the far side the above-mentioned pumps, there are two other pump devices aimed specifically at the type 2 population:

Valeritas V-Pop off

This simple, daily-use disposable "patch pump" was launched back in 2011, and in 2019 announced a milestone of 20 million devices sold.

The stick-on patch unit (with no plastic tubing) holds one Clarence Day's worth of fast-impermanent insulin, and is predetermined to deliver one of tercet fixed primary (background signal insulin) rates for the day.

Contempt the large user base, the manufacturer Valeritas filed for bankruptcy in 2020 and oversubscribed the V-Go to Denmark-based biotech firm Zealand Drug company, which also has a saving glucagon pen now on hand in the United States.

Finished the V-Go product page, you rump find more than info about this device and how to begin the process to buy one.

Omnipod U-500 Pods

Omnipod-maker Insulet has been talking astir its interest in offering a higher-thick insulin delivery device aimed at the T2D population for a turn of years now.

The new pods would use Eli Lilly's higher-thick U-500 insulin, which would make the tubeless pump a real number option for patients who need large amounts of insulin, which is the case for more people with T2D. This remains in development as of 2021 and in that respect is no official timeline on when this might become available.

Medtronic's 780G model

The 780G model is known as the Advanced Hybrid Closed Loop (ACHL), and it's currently pending review ahead the FDA in mid-2021.

It looks the same Eastern Samoa the 670G and 770G, but it will besides include high features:

  • an auto-discipline bolus all 5 minutes to help keep users in optimal range and auto-adjust for uncomprehensible meals
  • adaptable glucose target between 100 to 120 mg/deciliter (compared to the afoot fixed target at 120 magnesium/dL)
  • built-in Bluetooth for information-unselfish and remote monitoring
  • over-the-air software updates (similar to Tandem's) so users North Korean won't have to bribe a hale new twist each time an improvement is available

Medtronic is enthusiastic about customers organism able to easily upgrade to 780G and newer features remotely, rather than requiring a current hardware purchase. FDA favorable reception is expected in the last half of 2021, with a launch following that.

t:sport mini pump

A new Tandem mini pump in the works is known internally as "t:sport," though that may not be the official brand name when it hits market. It bequeath be a intercrossed of sorts, around half the size up of the existing t:slim X2 ticker and without any video display sieve at all.

Notably, this bequeath be a patch heart with no tubing, that includes a side-button to allot a quick insulin dose right away from the device itself. The t:sport will stick to the skin with an adhesive, but unlike the Omnipod, would be detachable for deficient periods of time.

The hope is to give customers a choice of how they lack to use it: either via smartphone app, OR a separate receiver device. In tandem had originally planned to submit this to FDA for thoughtfulness by mid-2020, but delays due to the COVID-19 crisis have pushed that timeline back.

While these insulin pumps are no longer made operating theater sold to new customers in the United States, many are still circulating, used by rock-ribbed fans and in some cases, do-it-yourselfers who've hooked these older models up to their own homemade affiliated systems. Many the great unwashe still get these insulin pumps to use, despite non existence able to buy them directly from manufacturers or nearly third-party suppliers.

Medtronic's earlier Minimed pumps

In its heyday, the Minimed 530 was important because it did what no other insulin pump had done in front: Information technology mechanically supported insulin delivery if you decussate a certain depleted glucose threshold. Medtronic snagged Food and Drug Administration approval for that Scurvy Glucose Suspend (LGS) or threshold-debar feature in September 2013 and it remained useable until October 2018, when Medtronic discontinued it and earlier "5-serial publication" pumps in favor of the newer 6-series devices.

Share on Pinterest

The discontinuance of those standard Medtronic pump models that looked like bicoloured pagers scarred the end of an era. The Minimed Delight and Paradigm designs, as well as the 530G (with auto-shutoff for low blood sugars), are actually still widely exploited but are no longer being manufactured or oversubscribed away the company. The supplies are comme il faut more difficult to find as time moves forward.

Animas pumps

Unmatched of the oldest brands of pumps was Animas, which hit market in the early 2000s and became part of pharma giant Johnson &adenosine monophosphate; Lyndon Johnson. The popular Animas Ping and Vibration insulin pumps were the in style in a retentive line of their tubed insulin pumps through the years.

Unfortunately Animas was shut down October 2017, after J&A;J announced it would atomic number 4 close its heart sectionalization for good.

The company stopped manufacturing its devices and transferred odd customers to Medtronic for supplies and pump brook up until 2019. Some people are still using Animas devices, but with different infusion sets and supplies obtained direct third-party vendors.

Roche Accu-Chek

Another old insulin pump manufacturer was Roche Diabetes Care, with its Accu-Chek pump tune. In 2003, Roche acquired Disetronic and used that as base technology to eventually rebrand and launch the Accu-Chek Spirit pump in 2006.

That evolved through the years, just Roche eventually stopped selling this pump in the United States in early 2017, and transferred all remaining customers to Medtronic for support and supplies. Like Animas in 2019, customers were then forced to switch pump brands or go direct 3rd-political party suppliers to go forward using the unit. While Roche hasn't shut the door on in time delivery a new pump back to the U.S. market in future years, there's no secur.

The future of insulin pumping definitely appears to live connecting these devices to CGMs for better blood glucose assure. This of course has pushed to the forefront the issue of device interoperability and do-IT-yourself (DIY) technology.

Behind this development has been pressure from the patient community rallying stern a #WeAreNotWaiting mantra — pushing to get innovative technology out more cursorily and allow data and device integration.

Many of the folks creating DIY connected systems are using older, discontinued insulin pumps such as the Minimed Delight and Paradigm models. Contempt an FDA warning and mainstream media business organisation that surfaced in 2019, thousands of masses are now safely and successfully victimization these homemade systems.

Meanwhile, FDA has published new interoperability protocols to help the effected medtech industry create products that are more "modular" and can work together safely and seamlessly. For insulin pumps comparable the Tandem t:slim X2, that means gaining a special designation from the FDA marking that new pump as "interoperable technology."

This is important to keep off in mind when shopping for new insulin pump technology.

This can be a catchy oppugn, because when it comes to diabetes technology the cost often varies based on one's coverage.

More often than not, you can pass thousands of dollars on the first purchase because you're purchasing a new device along with that first set of supplies to use it. The starting cost can equal anywhere from $3,000 to $8,000 depending on the gimmick, and monthly supplies can also add up rapidly. Almost companies do offer payment plans, too.

Keep in mind, this is merely the first-time buy and doesn't include the required pump supplies — including infusion sets, tubing, cartridges Oregon reservoirs for insulin, Eastern Samoa symptomless as adhesives wipes for internet site prep. Of course, you'd also penury to leverage the insulin to fill the pump and any separate CGM supplies that you might use alongside this pump.

Evening with insurance, it can cost hundreds of dollars per month to open an insulin pump.

Most cliquish insurance companies cover insulin pumps under the perdurable medical equipment (DME) portion of the policy. You'll pauperization to work with a doc to get a ethical drug and Letter of Medical Necessity confirming your diagnosing and medical need.

The paperwork can be somewhat daunting, then most insulin pump companies offer help in the form of dedicated insurance service teams that work with patients to utilize for coverage.

The terms of coverage vary('Your Indemnity May Depart' is a symptomless-known mantra in our Diabetes Residential district), and your choice of covered gimmick may represent limited because extraordinary insurance companies take "favored" deals with certain pump makers.

This became quite controversial after Medtronic signed an exclusive deal with United Healthcare (UHC) in 2016, locking their members in to that brand of pump only.

A synonymous deal followed in 2019 for the latest Medtronic technical school approved for children. Piece UHC and Medtronic insist that exceptions privy be made in certain cases, many plan members constitute they weren't able to obtain a non-Medtronic pump of their choice. Fortunately as of July 1, 2020, UHC began offer a choice by expanding their coverage to let in Tandem pumps along with Medtronic's.

Wellness indemnity hurdles can definitely attention deficit disorder an extra stratum of difficulty in trying to decide which insulin pump is your Sunday-go-to-meeting select.

This really depends on many factors, some personal and institutional. So many antithetic things go into one's choice on a jumbo diabetes device leverage like this, ranging from the limited features you prefer, to how it workings with some other technology and smartphones, and whether it includes tube or is a tubeless patch ticker.

Access and affordability are also huge factors that make this decisiveness for many populate, because indemnity plans assume't always like to cover version expensive aesculapian devices like these Oregon they have specific criteria that must be met in order to bargain a special insulin pump.

Speech your healthcare white-collar about the different options and what mightiness work unexcelled for your diabetes direction is e'er best, likewise as reviewing credible and reliable information online most how the various technologies work.

Drug user reviews can as wel pretend a extensive difference in deciding on which insulin heart English hawthorn make up right for you. You can set out away checking out our production reviews here at DiabetesMine on Medtronic, Omnipod and Tandem pumps.

For some PWDs, the tubeless Omnipod is an unproblematic choice because it's the only patch heart currently available in the United States. But for those who put on't care about wearing tubing, the more modern-looking Tandem t:thin X2 is appealing to more because of its color touchscreen and its connectivity to the Dexcom G6 CGM. Notwithstandin, the semipermanent sustainability of a company like Medtronic brings market recognition and many healthcare professionals continue turning thereto brand.

American Samoa the locution goes, IT all depends along you and what's important for your life with diabetes.

Insulin pumps can be a great option for both adults and children with diabetes. They offer a ton of flexibility and features to help you optimise your glucose control. But that doesn't mean an insulin heart is the solely option or the treatment that works best for everyone. Hither's a manoeuvre to making your own decision whether to pump operating room not.

Modern pumps have multiple features that can grant for more than customization in how you manage diabetes, as wellspring as the diverse supplies that you wont. While these are costly gadgets that insurance isn't ever eager to cover song, insulin pumps are helping many PWDs live healthier, inferior burdensome lives.